These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31411713)

  • 41. Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins.
    Hasegawa Y; Hori M; Nakagami T; Harada-Shiba M; Uchigata Y
    J Clin Lipidol; 2018; 12(1):62-69.e1. PubMed ID: 29217412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    Ikramuddin S; Korner J; Lee WJ; Thomas AJ; Connett JE; Bantle JP; Leslie DB; Wang Q; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Billington CJ
    JAMA; 2018 Jan; 319(3):266-278. PubMed ID: 29340678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of Quality Performance Measures for Patients Receiving In-Person vs Telemedicine Primary Care in a Large Integrated Health System.
    Baughman DJ; Jabbarpour Y; Westfall JM; Jetty A; Zain A; Baughman K; Pollak B; Waheed A
    JAMA Netw Open; 2022 Sep; 5(9):e2233267. PubMed ID: 36156147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
    Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distance from the endocrinology clinic and diabetes control in a rural pediatric population.
    LePage AK; Wise JB; Bell JJ; Tumin D; Smith AW
    J Pediatr Endocrinol Metab; 2021 Feb; 34(2):187-193. PubMed ID: 33544546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
    Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
    JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
    Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
    J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study.
    Kim JY; Choi J; Kim SG; Kim NH
    Cardiovasc Diabetol; 2022 Feb; 21(1):28. PubMed ID: 35193571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
    Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
    Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
    JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events.
    Korsnes JS; Davis KL; Ariely R; Bell CF; Mitra D
    J Manag Care Spec Pharm; 2015 Jun; 21(6):443-50. PubMed ID: 26011546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Care trajectories are associated with quality improvement in the treatment of patients with uncontrolled type 2 diabetes: A registry based cohort study.
    Goderis G; Van Casteren V; Declercq E; Bossuyt N; Van Den Broeke C; Vanthomme K; Moreels S; Nobels F; Mathieu C; Buntinx F
    Prim Care Diabetes; 2015 Oct; 9(5):354-61. PubMed ID: 25709079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
    Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial.
    House A; Bryant L; Russell AM; Wright-Hughes A; Graham L; Walwyn R; Wright JM; Hulme C; O'Dwyer JL; Latchford G; Meer S; Birtwistle JC; Stansfield A; Ajjan R; Farrin A
    Health Technol Assess; 2018 May; 22(26):1-328. PubMed ID: 29845932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.
    Kohli-Lynch CN; Bellows BK; Thanassoulis G; Zhang Y; Pletcher MJ; Vittinghoff E; Pencina MJ; Kazi D; Sniderman AD; Moran AE
    JAMA Cardiol; 2019 Oct; 4(10):969-977. PubMed ID: 31461121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sociodemographic disparities in the management of type 2 diabetes in the United States.
    Tan X; Lee LK; Huynh S; Pawaskar M; Rajpathak S
    Curr Med Res Opin; 2020 Jun; 36(6):967-976. PubMed ID: 32297530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.